These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 16739070

  • 41. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS, Thimmaiah P, Thimmaiah KN.
    Bioorg Med Chem; 2008 Jan 01; 16(1):474-87. PubMed ID: 17933543
    [Abstract] [Full Text] [Related]

  • 42. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption.
    Dey S, Gunda S, Mitra AK.
    J Pharmacol Exp Ther; 2004 Oct 01; 311(1):246-55. PubMed ID: 15175422
    [Abstract] [Full Text] [Related]

  • 43. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A, Watanabe H, Maeda Y, Yokoo K, Sanematsu E, Fujii J, Sasaki J, Hamada A, Saito H.
    Biochem Pharmacol; 2008 Feb 15; 75(4):973-80. PubMed ID: 18054347
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y.
    Leuk Res; 2009 Aug 15; 33(8):1114-9. PubMed ID: 19036441
    [Abstract] [Full Text] [Related]

  • 47. 3'-O, 4'-O-aromatic acyl substituted 7,8-pyranocoumarins: a new class of P-glycoprotein modulators.
    Shen X, Chen G, Zhu G, Cai J, Wang L, Hu Y, Fong WF.
    J Pharm Pharmacol; 2012 Jan 15; 64(1):90-100. PubMed ID: 22150676
    [Abstract] [Full Text] [Related]

  • 48. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 49. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
    Kataoka Y, Ishikawa M, Miura M, Takeshita M, Fujita R, Furusawa S, Takayanagi M, Takayanagi Y, Sasaki K.
    Biol Pharm Bull; 2001 Jun 28; 24(6):612-7. PubMed ID: 11411546
    [Abstract] [Full Text] [Related]

  • 50. Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents.
    Woodland C, Koren G, Wainer IW, Batist G, Ito S.
    Can J Physiol Pharmacol; 2003 Aug 28; 81(8):800-5. PubMed ID: 12897809
    [Abstract] [Full Text] [Related]

  • 51. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
    Angelini A, Di Pietro R, Centurione L, Castellani ML, Conti P, Porreca E, Cuccurullo F.
    J Biol Regul Homeost Agents; 2012 Aug 28; 26(3):495-504. PubMed ID: 23034269
    [Abstract] [Full Text] [Related]

  • 52. Analysis of random recombination between human MDR1 and mouse mdr1a cDNA in a pHaMDR-dihydrofolate reductase bicistronic expression system.
    Shoshani T, Zhang S, Dey S, Pastan I, Gottesman MM.
    Mol Pharmacol; 1998 Oct 28; 54(4):623-30. PubMed ID: 9765504
    [Abstract] [Full Text] [Related]

  • 53. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
    van Asperen J, Schinkel AH, Beijnen JH, Nooijen WJ, Borst P, van Tellingen O.
    J Natl Cancer Inst; 1996 Jul 17; 88(14):994-9. PubMed ID: 8667431
    [Abstract] [Full Text] [Related]

  • 54. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation.
    Ibrahim S, Peggins J, Knapton A, Licht T, Aszalos A.
    Anticancer Res; 2001 Jul 17; 21(2A):847-56. PubMed ID: 11396174
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
    Zeng H, Lin ZP, Sartorelli AC.
    Biochem Pharmacol; 2004 Sep 01; 68(5):911-21. PubMed ID: 15294454
    [Abstract] [Full Text] [Related]

  • 57. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.
    Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida O, Ueda K, Komano T.
    J Pharmacol Exp Ther; 1995 Oct 01; 275(1):73-8. PubMed ID: 7562598
    [Abstract] [Full Text] [Related]

  • 58. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF, Wan CK, Zhu GY, Chattopadhyay A, Dey S, Zhao Z, Shen XL.
    Planta Med; 2007 Mar 01; 73(3):212-20. PubMed ID: 17318783
    [Abstract] [Full Text] [Related]

  • 59. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
    Constable PA, Lawrenson JG, Dolman DE, Arden GB, Abbott NJ.
    Exp Eye Res; 2006 Jul 01; 83(1):24-30. PubMed ID: 16530756
    [Abstract] [Full Text] [Related]

  • 60. Mode of action of torilin in multidrug-resistant cancer cell lines.
    Kim SE, Hong YS, Kim YC, Lee JJ.
    Planta Med; 1998 May 01; 64(4):335-8. PubMed ID: 9619116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.